Analytical reproducibility in (1)H NMR-based metabonomic urinalysis.
about
Animal-Free Chemical Safety AssessmentMetabolomic fingerprinting: challenges and opportunitiesAnalysis of bacterial biofilms using NMR-based metabolomicsMetabolic changes in urine during and after pregnancy in a large, multiethnic population-based cohort study of gestational diabetes'Systems toxicology' approach identifies coordinated metabolic responses to copper in a terrestrial non-model invertebrate, the earthworm Lumbricus rubellusAssessment of metabolic phenotypic variability in children's urine using 1H NMR spectroscopyDiagnostic Applications of Nuclear Magnetic Resonance-Based Urinary MetabolomicsApplication of 31P NMR spectroscopy and chemical derivatization for metabolite profiling of lipophilic compounds in human serum.Automated annotation and quantification of metabolites in 1H NMR data of biological origin.Comparison of storage conditions for human vaginal microbiome studiesMetabonomics in toxicology: a review.(1)H NMR Metabolomics Study of Metastatic Melanoma in C57BL/6J Mouse Spleen.Human metabolic profiles are stably controlled by genetic and environmental variation.The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements.Metabonomics in preclinical drug development.Metabolic profiling technologies for biomarker discovery in biomedicine and drug development.Metabonomics in pharmaceutical R&D.Global metabolic profiling and its role in systems biology to advance personalized medicine in the 21st century.(1)H HR-MAS spectroscopy for quantitative measurement of choline concentration in amniotic fluid as a marker of fetal lung maturity: inter- and intraobserver reproducibility study.Metabonomic analysis of ovarian tumour cyst fluid by proton nuclear magnetic resonance spectroscopyPotential role of body fluid 1H NMR metabonomics as a prognostic and diagnostic tool.Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics.Application of metabonomics in drug development.How close is the bench to the bedside? Metabolic profiling in cancer research.Session 2: Personalised nutrition. Metabolomic applications in nutritional research.Signal intensities derived from different NMR probes and parameters contribute to variations in quantification of metabolites.The role of metabolic biomarkers in drug toxicity studies.Opening up the "Black Box": metabolic phenotyping and metabolome-wide association studies in epidemiology.¹H NMR-based metabonomics for investigating diabetes.Biofluid metabonomics using (1)H NMR spectroscopy: the road to biomarker discovery in gastroenterology and hepatology.Metabonomics approaches and the potential application in foodsafety evaluation.Metabolic phenotyping applied to pre-clinical and clinical studies of acetaminophen metabolism and hepatotoxicity.Coefficient of Variation, Signal-to-Noise Ratio, and Effects of Normalization in Validation of Biomarkers from NMR-based Metabonomics Studies.NMR and MS Methods for Metabolomics.Metabonomic investigation of human Schistosoma mansoni infection.Discovery of safety biomarkers for realgar in rat urine using UFLC-IT-TOF/MS and 1H NMR based metabolomics.NMR analysis of the human saliva metabolome distinguishes dementia patients from matched controls.Spectral relative standard deviation: a practical benchmark in metabolomics.A guide to the identification of metabolites in NMR-based metabonomics/metabolomics experiments.The Plasma and Serum Metabotyping of Hepatocellular Carcinoma in a Nigerian and Egyptian Cohort using Proton Nuclear Magnetic Resonance Spectroscopy.
P2860
Q26738977-FAED2C12-E499-4BE1-8420-905BF3D52F26Q26829105-10D0584D-1599-41EF-A110-7B94DFCF001EQ26851303-F24E2CBD-A8F8-41EF-9AD6-B866BB6F657CQ28484522-E15FEA68-3FB5-4140-9326-15B85C0B7B1CQ33340135-F10BB6E2-FD50-4639-99B1-A576BC1ABEB6Q33576589-D686C697-CBD2-456B-9C85-AA07A16F2A80Q33670799-BE27D9E0-6001-4422-94CC-13C5E94ED030Q33816151-135B2E85-1E7C-42BA-8722-96245A493098Q34169403-3CAFCFEF-1B12-4CB1-9DF6-219F28156973Q34288886-4A2922F4-6F3A-4A3E-A329-49BA1A7FDEDFQ34390625-0E60ADE3-4627-46A0-8366-8BBC5E0463FBQ34453064-A4CB9093-D380-4DA7-97AC-DD41641D4766Q35458562-DA89AD7B-C8FB-4045-A438-1F0CC89E9659Q36278011-BE497EC7-3B83-48BA-9CFD-E8C7AEFB030FQ36544940-E6F08A64-D2E8-4BD0-BC87-FBD5B69E17C4Q36629997-6192E2F1-52DE-4A75-9C09-4A00463BE47CQ36735003-39E0A13A-D8A9-4469-BADC-3E18AC62630AQ36816026-91F5C8EE-D1BC-4C9F-9765-824BA25B2A6FQ36893982-3D314406-C69D-43F1-8B65-C45ADB40E488Q36916442-7A96CD1E-21BC-4F31-8243-54C3A5E6914AQ37004622-6D411114-83FA-43A6-888E-F824DAAFFA2BQ37004712-D4ADFBAA-5B54-4AEE-8A21-E5764A32440FQ37074082-98002C13-FE1C-4C6A-BFE5-49084CF1A2A3Q37118287-72CCEC34-AE97-42B3-A36B-8CF0192E53E5Q37291407-67818343-4FEE-4987-8953-E134DC74D624Q37499674-FCDA0EAB-3D96-49D6-8930-F6103A515840Q37658689-F3E164A8-0286-4F3D-80F1-674F4755A376Q37670437-612B6904-D9BE-45FE-A43F-59777D1B697DQ37855850-614FDE0D-A6D1-4AED-9473-7FFA31D3F597Q37989165-630B2640-348F-49C0-8828-1542FAC47DB7Q38018710-74E7374C-5C3B-4911-8877-B996F10204C2Q38297772-F8A8C1C8-78DE-41A2-BB10-67E18AD45872Q38425546-7505BAC5-C6E3-47ED-BB9F-76E716F5F9AEQ38658442-C772BF63-579F-4119-8340-2E53B0822206Q38870788-05812A42-67D1-41B4-9389-2D0B9AF3188BQ39453822-47E891D3-28B4-4A12-80A5-51E31AD505DCQ39707600-F9273B34-72D6-4AAE-B0E3-8D33A7383857Q39880397-8B4B8687-4F50-4449-B2DA-FE2F50E259B9Q39884399-15A90BAA-32D4-45C6-9435-E26E67645118Q40140466-AAF16AEA-290E-4A3D-902C-FAA70B32912E
P2860
Analytical reproducibility in (1)H NMR-based metabonomic urinalysis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Analytical reproducibility in (1)H NMR-based metabonomic urinalysis.
@ast
Analytical reproducibility in (1)H NMR-based metabonomic urinalysis.
@en
type
label
Analytical reproducibility in (1)H NMR-based metabonomic urinalysis.
@ast
Analytical reproducibility in (1)H NMR-based metabonomic urinalysis.
@en
prefLabel
Analytical reproducibility in (1)H NMR-based metabonomic urinalysis.
@ast
Analytical reproducibility in (1)H NMR-based metabonomic urinalysis.
@en
P2093
P356
P1476
Analytical reproducibility in (1)H NMR-based metabonomic urinalysis.
@en
P2093
Elaine Holmes
Götz Schlotterbeck
Hector C Keun
Henrik Antti
John C Lindon
Mary E Bollard
Olaf Beckonert
Timothy M D Ebbels
Urs Niederhauser
P304
P356
10.1021/TX0255774
P577
2002-11-01T00:00:00Z